Akinchan Bhardwaj: Exercise Biological Modifier of Vascular Trajectory
Akinchan Bhardwaj, Consultant Interventional Cardiologist at Kauvery Hospital, shared a post on LinkedIn:
“If exercise were a drug, we would call it multi-target vascular therapy.
Exercise is often framed as ‘cardiovascular risk reduction.’ But that description undersells what it actually does.
Exercise is not simply a statistical modifier of event probability.
It is a biological modifier of vascular trajectory.
Regular physical activity has been shown to:
- Improve endothelial nitric oxide bioavailability
- Reduce systemic inflammatory tone
- Enhance insulin sensitivity independent of weight loss
- Improve autonomic balance and blood pressure variability
- Influence plaque phenotype toward more stable morphology
Most pharmacologic therapies act on a single pathway.
Exercise simultaneously influences lipid metabolism, inflammation, metabolic pressure and vascular function.
If cardiovascular risk is a curve, exercise does not just shift it downward. It reduces its slope.
That distinction matters as we rethink prevention in an era of genomics, AI and precision risk modeling.
I explore this in my latest CardioForesight essay:
‘Exercise Doesn’t Just Lower Risk, It Changes Vascular Biology.'”

Stay updated with Hemostasis Today.
-
Jun 24, 2026, 16:32Arlindo Nascimento de Lemos Junior: Thrombus Echogenicity as a Predictor of Post-Thrombotic Syndrome Severity After DVT
-
Jun 24, 2026, 16:09Jimi Olaghere: The Future of Sickle Cell Disease Research Starts With Collaboration
-
Jun 24, 2026, 16:03Von Willebrand Disease as a Common Yet Under-Recognised Bleeding Disorder – EHC
-
Jun 24, 2026, 15:57Maia Meier: Women with Bleeding Disorders Reach the Summit of Mont Blanc
-
Jun 24, 2026, 15:40Annette Bowyer: The Emerging Role of Extravascular Factor VII in Haemostasis
-
Jun 24, 2026, 13:50Tijjani Balas: Why Early Detection of DVT Matters
-
Jun 24, 2026, 13:43Brandon Michael Henry: Interpreting Complement Activation After AAV Gene Therapy
-
Jun 24, 2026, 13:37Heba Youssef: Heparin-Induced Thrombocytopenia – The Prothrombotic Emergency You Cannot Miss
-
Jun 24, 2026, 13:32Jecko Thachil: Understanding the Clinical Spectrum of Vitamin B12